Follow the Finnish Lead in Peer Review

I usually feel happier reviewing a grant application from the U.S. National Science Foundation than one sent by the Science and Engineering Council here in Britain, where I am much more likely to know the applicant personally," a biochemist told me recently. A staunch supporter of peer review, he was nevertheless uncomfortably aware of the distortions, unfairness and even abuses that can flaw this time-honored principle of scholarly intercourse. He even suggested that the contemporary problem of

Written byBernard Dixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Perhaps this approaches timorous irresponsibility. Yet my companion's general argument has undoubted merit. The opinions we express in public often differ from those vouchsafed under the cloak of secrecy. Within science, this disparity is said to justify anonymity in the refereeing of both research papers and grant applications. Peer review is designed to harness the critical faculties of scholars, distanced from personal likes or dislikes by the guarantee of confidentiality.

In practice, such idealism is often unattainable. Every journal editor can recount many stories of ideas stolen and old scores settled by reviewers, and of the frantic efforts of would-be authors to identify referees who have allegedly killed stone dead their chances of winning next year's Nobel Prize. In the realm of funding, where the stakes are even higher, there are corresponding charges of malfeasance and occasional suspicions of corruption. In short: although peer review can, and sometimes does, work ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies